| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharma/NIH) | Year complete | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| DRCR Retina Network Protocol T (Change in Diabetic Retinopathy Through 2 Years Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab) | 650 | National Eye Institute and the National Institute of Diabetes and Digestive and Kidney Diseases | 2017 |
Bressler SB, Liu D, Glassman AR, et al. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab. JAMA Ophthalmol. 2017;135:558-568. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2621880 |